Altimmune(ALT) - 2025 Q4 - Earnings Call Transcript
Altimmune(US:ALT)2026-03-05 14:32Altimmune (NasdaqGM:ALT) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsAnnabel Samimy - Managing DirectorBoris Peaker - Managing DirectorChristophe Arbet-Engels - Chief Medical OfficerGreg Weaver - CFOJerry Durso - President and CEOLee Roth - PresidentLinda Richardson - Chief Commercial OfficerMichael DiFiore - Managing DirectorScot Roberts - Chief Scientific OfficerConference Call ParticipantsAndy Hsieh - Biotech Research AnalystRoger Song - Senior Equity Research AnalystWilliam Wood ...